Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
6-(Bromomethyl)nicotinonitrile has been used as a reactant in the synthesis of oxadiazoles as selective S1P receptor agonists that may be used in the treatment of relapsing forms of MS.